SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 28.10+5.6%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (10728)7/11/1999 11:48:00 AM
From: aknahow  Read Replies (1) of 17367
 
Robert, this is what I posted;

<<<<<<
This means the 90 day look back for 370 occurred June 9. All those accrued from
March 9 thru April 13 will
have also completed the 90 day look back period. We also know that from March 9
thru April 13 the accrual rate
was declining, week by week. Would guess that of the 25 accrued from March 9
thru April 13 about 2/3 of the
25 were accrued with 1/3 or only 8 in the final month. Say even 10, this would still
mean 15 more could be
added to the 370 to produce a total of 385 who probably completed the 90 day look
back period by July 13.>>>>>>>>

These look back periods exist. What the subject data revealed at these points is available
only at un blinding.

Since a total of 395 patients were accrued, I was pointing out that only 25 of them were
accrued between March 9 and May 13 when it was announced that the trial was
concluded. We already know that XOMA has the ability to look at the data once all
subjects have passed the 60 day look back point.

I contend none of us know if XOMA or any company has the ability to unblind a trial before all look back points have been reached.
XOMA apparently does not intend to un blind on 13 July, according to Murphy.
XOMA has said it will unblind sometime between July 13 and Aug. 13.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext